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Aim
Infection of native arteries and/or prosthetic material is
one the most frequent indications to use cryopreserved
arterial homografts. For more than 20 years the European
Homograft Bank (EHB) has been delivering cryopreserved
homografts for the treatment of aortic infections to differ-
ent implanting centres in Europe and elsewhere.
Material and methods
This paper presents the results of treatment of aortic
infection with homografts for diverse indications.
The descending thoracic aortas are recovered during the
multi-organ donation (MOD), transferred to the EHB in a
cold saline solution (+4°C), decontaminated in a triple
antibiotic cocktail for up to 48 hours and cryopreserved
using the 10% of dimethyl sulfoxide (DMSO) in Hank’s
199 solution. They are cryopreserved by a control-rate-
freezing of 1°C/minute down to -40°C and 5°C/min down
to -150°C, then stored in liquid nitrogen vapors at a tem-
perature ≤-135°C up to five years. The tissues are delivered
to the implanting surgeon on basis of the clinical indica-
tion and the state of emergency.
Preliminary results
Over 20 years, 2,705 arterial segments were delivered for
implantation, of which 430 thoracic aortas. 68% of those
aortic segments were used for infection related problems
(60% for replacement of the infected prosthetic material
and 8% for native aortas, mainly for mycotic aneurysms).
About 30% of the aortic homografts were used for aortic
surgery for non-infectious problems, such as aortic coarc-
tation, hypoplastic arch, malignant infiltration of arterial
tree, heart transplantation, prosthetic graft thrombosis
or trauma of native arteries. The follow-up of these
implanted homografts is in course.
Conclusion
Aortic homografts are highly resistant against the infection
and can offer good long term results for the treatment of
infection problems in aortic surgery. The follow-up data
will be presented at the Congress venue. Despite very
important need for aortic homografts, the offer remains
scarce, due to a low donation rate in different countries
and a high rate of contaminated tissues during the recov-
ery procedure.
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